Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW) | MicrobiomeTrials← Back to trialsNCT07161037
Phase 2a Study of VX-407 in Participants With ADPKD Who Have a Subset of PKD1 Gene Variants (AGLOW)
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2025-11-19Est. Completion: 2027-07-22
Enrollment target: 24 participants Locations- Alabama Kidney Research, Alabaster, Alabama, United States
- UAB Nephrology Research at CH19, Birmingham, Alabama, United States
- Kaiser Permanente Los Angeles Medical Center, Los Angeles, California, United States
- UCSF Clinical Research Center at Parnassus, San Francisco, California, United States
- Nephrology & Hypertension Associates, PC, Middlebury, Connecticut, United States
- Yale University - Yale Nephrology Clinical Research Clinic, New Haven, Connecticut, United States
- Mayo Clinic - Jacksonville, Jacksonville, Florida, United States
- Emory School of Medicine - Renal Division, Atlanta, Georgia, United States
- Renal Associates, Columbus, Georgia, United States
- UChicago Medicine - Duchossois Center for Advanced Medicine - Nephrology, Chicago, Illinois, United States
- University of Iowa Health Care Medical Center- Nephrology, Iowa City, Iowa, United States
- Clinical & Translational Science Unit (CTSU) - Nephrology, Kansas City, Kansas, United States
- University of Maryland Medical Center - General Clinical Research Center, Baltimore, Maryland, United States
- Tufts Medical Center, Boston, Massachusetts, United States
Other microbiome trials you might be interested in
ADPKD
Autosomal Dominant Polycystic Kidney Disease (ADPKD) is the most common genetic cause of renal failure. For several deca…
Washington D.C., United StatesEst. completion Oct 30, 2030
Polycystic Kidney, Autosomal Dominant
Autosomal dominant polycystic kidney disease is the most common genetic cause of kidney failure. The only approved treat…
Feldkirch, AustriaEst. completion May 15, 2030
Beth Israel Deaconess Medical Center - Nephrology, Boston, Massachusetts, United StatesUniversity of Minnesota -Clinics and Surgery Center (CSC) - Endocrine Clinic, Minneapolis, Minnesota, United StatesMayo Clinic - Rochester, Rochester, Minnesota, United StatesDaVita Kidney Care - Las Vegas, Las Vegas, Nevada, United StatesThe Rogosin Kidney Center, New York, New York, United StatesGeneral Nephrology Clinic - New York City, New York, New York, United StatesCleveland Clinic - Main Campus, Cleveland, Ohio, United StatesGeisinger Clinic, Danville, Pennsylvania, United StatesPerelman Center for Advanced Medicine - Nephrology, Philadelphia, Pennsylvania, United StatesNephrology Clinical Trials Center, Nashville, Tennessee, United StatesUVM Medical Center - 1 South Prospect Street, Burlington, Vermont, United StatesSwedish Center for Comprehensive Care, Seattle, Washington, United StatesUniversite Catholique de Louvain - Nephrology, Brussels, BelgiumUniversitaire Ziekenhuizen Leuven - Campus Gasthuisberg - Nephrology, Leuven, BelgiumMcGill University Health Centre, Montreal, CanadaCentre Hospitalier Regional Universitaire (CHRU) Brest, Brest, FranceHopital Necker Enfants Malades - Neurology, Paris, FranceHopital Bretonneau, Tours, FranceCharité - Klinik für Nephrologie und Intensivmedizin der, Berlin, GermanyUniversity Hospital Cologne (Koeln) - Nephrologie, Rheumatologie, Diabetologie und Allgemeine Innere Medizin, Cologne, GermanyUMCG - Nephrology, Groningen, NetherlandsFundacio Puigvert, Barcelona, SpainHospital Fundacion Jimenez Diaz, Madrid, SpainQueen Elizabeth Hospital Birmingham, Birmingham, United KingdomKing's College Hospital - Pulmonology, London, United KingdomRoyal Free Hospital - Nephrology, London, United KingdomSt George's Hospital London - Nephrology, London, United KingdomNewcastle upon Tyne Hospitals NHS Foundation Trust - Freeman Hospital - Nephrology, Newcastle upon Tyne, United KingdomNorthern General Hospital, Sheffield, United Kingdom